BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 28, 2026; 32(24): 118757
Published online Jun 28, 2026. doi: 10.3748/wjg.118757
Figure 2
Figure 2 Kaplan-Meier curves for time to treatment failure in enrolled patients with and without sarcopenia. The time to treatment failure of the sarcopenic group (dotted blue line) was significantly shorter than that of the non-sarcopenic group (solid orange line) (P < 0.001, log-rank test). The median time to treatment failure in the sarcopenic and non-sarcopenic groups were 59 and 211 days, respectively.


Write to the Help Desk